NYT goes to town on drug factory failings

By Nick Taylor

The New York Times has run a big feature on failings at pharmaceutical manufacturing plants. Problems at Hospira ($HSP), Ben Venue and other sterile injectable plants are dragged up as the NYT shows that it's not just compounding pharmacies that have quality issues. "In the industry, everyone knows that all of the factories are in terrible shape," an academic said. Article

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.